Vulnerability · CVE-2025-50675
GPMAW 14, a bioinformatics software, has a critical vulnerability related to insecure file permissions in its installation directory.
Published Aug 7, 2025 · catalog updated Aug 8, 2025 · GPMAW 14, a bioinformatics
Last checked Oct 28, 2026. A connected source was read within the last 7 days.
Check if you run it
No confirmed exploitation is on record for CVE-2025-50675. EPSS is 0.25%. Act only if a listed version of GPMAW 14, a bioinformatics is installed.
Gaps on this record
- The stored product name is a package slug. The name on this page is taken from the title (GPMAW 14, a bioinformatics).
- No version range is stored. A customer cannot check an installed version against this record.
- No vendor fix or required action is stored. Compare the linked advisory before you change production.
Same product and reporting
- CVE-2026-107079 · Unknown
- CVE-2026-95168 · High
- CVE-2025-60475 · Medium
- CVE-2025-60494 · Unknown
- CVE-2025-60496 · Unknown
- Severity
- High7.8
- Known exploitation
- Not in CISA/VulnCheck KEV
- EPSS
- 0.25%
- Remediation
- Vendor / distro source
- Affected products
- vendor n/a n/a n/a
GPMAW 14, a bioinformatics software, has a critical vulnerability related to insecure file permissions in its installation directory. The directory is accessible with full read, write, and execute permissions for all users, allowing unprivileged users to manipulate files within the directory, including executable files like GPMAW3.exe, Fragment.exe, and the uninstaller GPsetup64_17028.exe. An attacker with user-level access can exploit this misconfiguration by replacing or modifying the uninstaller (GPsetup64_17028.exe) with a malicious version. While the application itself runs in the user's
Are you affected?
Enter the version you run. The result uses only the ranges stored on this record.
The check returns affected, not affected, or incomplete. It does not guess a version that is missing from the record.
- vendor n/a n/a n/an/a
How to fix CVE-2025-50675
No stored fix
No vendor fix text is stored. Use the linked advisory before you change production.
Version check
No version range is stored, so an installed version cannot be checked on this page.
Advisory
Open the cve_org record and follow its fix.
Official advisories
What to do
Three questions, each answered from this record only. Confirm the vendor advisory before you patch.
Should you patch?
No confirmed exploitation is on record for CVE-2025-50675. EPSS is 0.25%. Act only if a listed version of GPMAW 14, a bioinformatics is installed.
Which versions are affected?
Compare what you have installed with n/a n/a n/a n/a. Compare the installed version with the linked vendor advisory before you change production.
What should an analyst verify?
No weakness class is stored. EPSS 0.25%. There is no CISA KEV listing. No Exploit-DB or Metasploit reference is linked. Use the source links for the original advisory.
Code
The project this record applies to. Exploit listings stay in References.
Timeline
Detection, updates, and resolution for this record.
Aug 7, 2025 · EUVD
Detected
GPMAW 14, a bioinformatics software, has a critical vulnerability related to insecure file permissions in its installation directory. The directory is accessible with full read, write, and execute permissions for all users, allowing unprivileged users to manipulate files within the directory, including executable files like GPMAW3.exe, Fragment.exe, and the uninstaller GPsetup64_17028.exe. An atta
Aug 8, 2025 · EUVD
Updated
GPMAW 14, a bioinformatics software, has a critical vulnerability related to insecure file permissions in its installation directory. The directory is accessible with full read, write, and execute permissions for all users, allowing unprivileged users to manipulate files within the directory, including executable files like GPMAW3.exe, Fragment.exe, and the uninstaller GPsetup64_17028.exe. An atta
Sources
- CVE.orgVulnerability recordCVE-2025-50675
Official CVE identifier
cve.org - FIRST EPSSExploitation probabilityCVE-2025-50675
30-day exploitation probability 0.25%
first.org - EUVDVulnerability recordEUVD-2025-23937
GPMAW 14, a bioinformatics software, has a critical vulnerability related to insecure file permissions in its installation directory. The directory is accessible with full read, write, and execute permissions for all users, allowing unprivileged users to manipulate files within t
euvd.enisa.europa.eu
References
Freshness
Last verified in this catalog Oct 28, 2026. Significant claims (KEV, EPSS, CVSS, affected ranges) come from the source rows above — open the original publisher for the authoritative advisory.
- FIRST EPSSOct 28, 2026
- CVE.orgOct 21, 2026
- EUVDOct 20, 2026